DAVITA INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
DAVITA INC. (DVA) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2026-02-11
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2025-09-30 was $0.00.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2025-06-30 was $0.00.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2024 was $109.47M.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2023 was $0.00.
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2022 was $0.00.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $0.00 10-Q · filed 2025-10-29 | $74.32M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $74.32M derived: sum of 3 quarters · filed 2026-02-11 | $74.32M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $74.32M derived: sum of 2 quarters · filed 2026-02-11 | $74.32M derived: sum of 3 quarters · filed 2026-02-11 | $74.32M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | $74.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $74.32M derived: sum of 2 quarters · filed 2026-02-11 | $74.32M derived: sum of 3 quarters · filed 2026-02-11 | $109.47M 10-K · filed 2026-02-11 |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $35.15M 10-Q · filed 2025-10-29 | $35.15M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $35.15M 10-Q · filed 2025-08-05 | $35.15M derived: sum of 3 quarters · filed 2026-02-11 | $35.15M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $35.15M 10-Q · filed 2025-05-12 | $35.15M derived: sum of 2 quarters · filed 2026-02-11 | $35.15M derived: sum of 3 quarters · filed 2026-02-11 | $35.15M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-13 | |||
| 2018-12-31 | $28.15M 10-K · filed 2019-02-22 | $28.15M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |